Results 71 to 80 of about 37,262 (190)

N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells

open access: yesFrontiers in Endocrinology, 2022
Chronic inflammation of pancreatic islets is a key driver of β-cell damage that can lead to autoreactivity and the eventual onset of autoimmune diabetes (T1D).
Joshua A. Nord   +8 more
doaj   +1 more source

Bromodomains: pockets with therapeutic potential

open access: yesTrends in Molecular Medicine, 2014
Intense interest in the complex biology of the bromodomain (BRD) protein modules has fueled the development of novel small molecule inhibitors that target the acetyl-lysine (KAc) binding pocket of the BRD. BRD inhibition has revealed exciting opportunities for treating a variety of maladies such as cancer, inflammation, obesity, cardiovascular disease,
Papavassiliou, Kostas A.   +1 more
openaire   +3 more sources

Theoretical Studies of Several Small-Ring Precursors to (+)-JQ1 [PDF]

open access: yes, 2013
We present the results of DFT(B3LYP) calculations on several precursors to (+)-JQ1 using an accurate basis set, including a report of conformational analysis, thermochemistry, optimized geometries and electrostatic potentials, and calculated IR and Raman
Atkinson, Elizabeth J. O.   +2 more
core   +1 more source

Chemical synthesis of the ATAD2 bromodomain [PDF]

open access: yesProceedings of the National Academy of Sciences, 2014
Significance The bromodomain–histone binding motif has been shown to read epigenetic marks on chromatin, and proteins with a bromodomain can have powerful effects on gene expression and transcriptional regulation. ATAD2 is one such protein and has been linked to a wide variety of cancers with expression of ATAD2 correlating strongly with a ...
Gardner S, Creech   +3 more
openaire   +2 more sources

Is now the time for molecular driven therapy for diffuse large B-cell lymphoma? [PDF]

open access: yes, 2017
INTRODUCTION: Recent genetic and molecular discoveries regarding alterations in diffuse large B-cell lymphoma (DLBCL) deeply changed the approach to this lymphoproliferative disorder.
Ansuinelli, Michela   +4 more
core   +1 more source

Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains [PDF]

open access: yes, 2018
Bromodomains have been pursued intensively over the past several years as emerging targets for the development of anticancer and anti-inflammatory agents.
Alessi, Dario R.   +27 more
core   +3 more sources

Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development [PDF]

open access: yes, 2017
Parasitic infections remain one of the most pressing global health concerns of our day, affecting billions of people and producing unsustainable economic burdens.
Huang, Sherri   +3 more
core   +1 more source

Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential

open access: yesAdvanced Science
The fungal Bromodomain and Extra‐Terminal (BET) protein Bdf1 is a potential antifungal target against invasive fungal infections. However, the need to selectively inhibit both Bdf1 bromodomains (BDs) over human orthologs and the lack of molecular tools ...
Kaiyao Wei   +22 more
doaj   +1 more source

Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology [PDF]

open access: yes, 2016
Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug discovery. Recent years have seen an explosion of interest in developing small molecules binding to bromodomains, the readers of acetyl-lysine modifications.
Alessio Ciulli   +3 more
core   +2 more sources

Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. [PDF]

open access: yes, 2019
Pancreatic ductal adenocarcinoma (PDAC) remains a deadly disease with no efficacious treatment options. PDAC incidence is projected to increase, which may be caused at least partially by the obesity epidemic.
Eibl, Guido, Rozengurt, Enrique
core  

Home - About - Disclaimer - Privacy